Related Experiment Video
Updated: Apr 15, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
New secondary metabolites isolated from Streptomyces species
William J Price Cunliffe1, Peter J Rutledge1,2
1School of Chemistry, The University of Sydney, Camperdown, Sydney, NSW 2006, Australia. peter.rutledge@sydney.edu.au.
Abstract:
Covering: 2021 to 2024Streptomyces species have long been recognised as prolific sources of novel natural products, generating a wide array of clinically-relevant antimicrobial and cytotoxic compounds. In this review, we examine 174 publications from 2021 to 2024 that describe 716 previously unreported secondary metabolites isolated from Streptomyces strains sourced from a range of marine and terrestrial environments. Natural product researchers used a variety of chemical and biological techniques, including genome mining, molecular networking, and heterologous expression, to uncover novel compounds with a diverse array of structures, including cyclic and linear peptides, macrocyclic, polyaromatic, and other polyketides, terpenoids, alkaloids, and azoxy compounds, among others. The variety of bioactivities exhibited by these secondary metabolites, including antibacterial, anticancer, antifungal, antiviral, and anti-inflammatory effects, illustrates the enduring potential of the Streptomyces genus to produce promising new bioactive natural products.
Related Concept Videos
Bacterial Phylum Actinobacteria
Production of Antibiotics
Special Staining Techniques
Bacterial Phylum Planctomycetes
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis

